VOR - Vor Biopharma - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

VOR is currently covered by 8 analysts with an average price target of $10.88. This is a potential upside of $10.7 (5944.44%) from yesterday's end of day stock price of $0.18.

Vor Biopharma's activity chart (see below) currently has 15 price targets and 40 ratings on display. The stock rating distribution of VOR is 100% BUY.

Stock Analyst Price Targets - Review

Highest price target for VOR is $3, Lowest price target is $3, average price target is $7.

Most recent stock forecast was given by SILVAN TUERKCAN from JMP on 30-Dec-2024. First documented stock forecast 02-Mar-2021.

Currently out of the existing stock ratings of VOR, 25 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

5 months 15 days ago
(30-Dec-2024)

0/6 (0%)

$9.12 (316.67%)

Buy

6 months 4 days ago
(10-Dec-2024)

0/5 (0%)

$12.58 (255.69%)

Buy

$22

7 months 6 days ago
(08-Nov-2024)

0/2 (0%)

$16.12 (274.15%)

Buy

$3

$2 (200.00%)

$10

10 months ago
(14-Aug-2024)

0/4 (0%)

$2.17 (261.45%)

Buy

1 years 1 months 1 days ago
(13-May-2024)

0/4 (0%)

$13.58 (307.24%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is VOR (Vor Biopharma) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on VOR (Vor Biopharma) with a proven track record?

SWAYAMPAKULA RAMAKANTH

Which analyst has the current lower performing score on VOR (Vor Biopharma) with a proven track record?

DAVID NIERENGARTEN

Which analyst has the most public recommendations on VOR (Vor Biopharma)?

Swayampakula Ramakanth works at HC WAINWRIGHT and has 3 price targets and 5 ratings on VOR

Which analyst is the currently most bullish on VOR (Vor Biopharma)?

John Walsh with highest potential upside - $15.79

Which analyst is the currently most reserved on VOR (Vor Biopharma)?

Swayampakula Ramakanth with lowest potential downside - -$0

Vor Biopharma in the News

Vor Bio Announces Exploration of Strategic Alternatives to Maximize Shareholder Value

CAMBRIDGE, Mass., May 08, 2025 (GLOBE NEWSWIRE) — Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that, based on currently available clinical data from its key clinical programs and a challenging fundraising environment, the Board of Directors has approved the initiation of a process to explore a range of strategic...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?